Clinical trial · Interventional
A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1
NCT05184829CI-TRIAL-00055905not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5-1
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Postoperative Recovery | — | UNRESOLVED | — |
| Progression | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| selective lymph node dissection | Other | — | UNRESOLVED |
| Systemic Lymph Node Dissection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- systemic lymph node dissection group
- description
- systemic lymph node dissection group
- interventionNames
- Other: Systemic Lymph Node Dissection
- type
- EXPERIMENTAL
- label
- selective lymph node dissection
- description
- selective lymph node dissection
- interventionNames
- Other: selective lymph node dissection
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- From enrollment to 36 months after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 25 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: Patients enrolled in the study must meet all of the following conditions: * 1.Aged between 25 and 75 years; * 2\. GGO is diagnosed by thin-section lung CT (thickness \<1.5mm) within one month before surgery; * 3\. The maximum diameter of the GGO is smaller than 3cm; * 4\. The solid component in GGO between 50%-100%; * 5\. Preoperative examination showed that the patient could tolerate lobectomy; * 6\. The patient is able to understand and comply with the study and has provided written informed consent. Exclusion Criteria: Patients meeting any of the following criteria are not eligible for this trial: * 1\. Patients with a history of lung surgery; * 2\. Postoperative pathology showed non-primary lung cancer; * 3\. The scope of surgical resection is larger than one lung lobe; * 4\. Patients with a history of other tumors; * 5\. Patients with severe complications (coronary heart disease, valvular heart disease, end-stage renal disease, severe liver cirrhosis); * 6\. Unable to cooperate with the researchers because of dementia or cognitive decline * 7\. Other situations that are not in conformity with the standards and requirements of this trial.
References
Publications (0)
Data not yet available
No reference posted for this study.